AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.30 and traded as low as $0.13. AdvanSource Biomaterials Corpration shares last traded at $0.13, with a volume of 41,000 shares trading hands.
Separately, ValuEngine downgraded shares of AdvanSource Biomaterials Corpration from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th.
The firm’s 50-day moving average is $0.90 and its 200-day moving average is $0.30. The firm has a market cap of $2.60 million, a price-to-earnings ratio of 12.10 and a beta of -2.34.
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend.
Read More: Backdoor Roth IRA Conversion and Strategy
Receive News & Ratings for AdvanSource Biomaterials Corpration Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSource Biomaterials Corpration and related companies with MarketBeat.com's FREE daily email newsletter.